Physician profile
Henry D Eikel
NPI 1366443467
$982.90
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $65.03 · 2021: $243 · 2022: $57.10 · 2023: $229 · 2024: $93.60 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $617.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $282.85 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $177.30 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Supernus Pharmaceuticals, INC. | $113.02 | 2021-2025 | Qelbree, Qelbree |
| Pfizer INC. | $70.37 | 2021 | |
| Ironshore Pharmaceuticals INC. | $52.13 | 2020-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $46.61 | 2021-2025 | |
| Global Blood Therapeutics, INC. | $39.17 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $38.20 | 2025 | Zoryve |
| Hologic Sales and Service, LLC | $32.23 | 2023 | Affirm Prone Biopsy System |
| Takeda Pharmaceuticals U.S.A., INC. | $31.47 | 2021 | |
| Noven Therapeutics, LLC | $24.41 | 2025 | Xelstrym |
| Astrazeneca Pharmaceuticals LP | $18.39 | 2023 | Flumist Quadrivalent |
| Seqirus USA INC | $15.68 | 2021 | |
| Collegium Pharmaceutical, INC. | $14.33 | 2025 | Jornay Pm |
| Acadia Pharmaceuticals INC | $13.58 | 2023 | Daybue |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Eikel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.